Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic regimens for tumor recurrence remain mostly individualized. The role of a surgical resection of recurrent glioblastomas remains largely unclear at present. This study aimed to assess the effect of repeated resection of recurrent glioblastomas on patient survival. METHODS: In a multicenter retrospective-design study, patients with primary glioblastomas undergoing repeat resections for recurrent tumors were evaluated for factors affecting survival. Age, Karnofsky performance status (KPS), extent of resection (EOR), tumor location, and complications were assessed. RESULTS: Five hundred and three patients (initially diagnosed between 2006 and 2010) undergoing resections for recurrent glioblastoma at 20 institutions were included in the study. The patients' median overall survival after initial diagnosis was 25.0 months and 11.9 months after first re-resection. The following parameters were found to influence survival significantly after first re-resection: preoperative and postoperative KPS, EOR of first re-resection, and chemotherapy after first re-resection. The rate of permanent new deficits after first re-resection was 8%. CONCLUSION: The present study supports the view that surgical resections of recurrent glioblastomas may help to prolong patient survival at an acceptable complication rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
An extent of resection threshold for newly diagnosed glioblastomas: Clinical article
Sanai, N., Polley, M.-Y., McDermott, M. W., Parsa, A. T., & Berger, M. S. (2011) · Journal of Neurosurgery · doi:10.3171/2011.2.jns10998 · Cited by 1,646
Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3055 · Cited by 1,577
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
Stummer, W., Reulen, H.-J., Meinel, T., Pichlmeier, U., Schumacher, W., Tonn, J.-C., Rohde, V., Oppel, F., Turowski, B., Woiciechowsky, C., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000317304.31579.17 · Cited by 1,035
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Glioblastoma survival in the United States before and during the temozolomide era
Johnson, D. R., & O’Neill, B. P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0749-4 · Cited by 720
van den Bent, M. J., Brandes, A. A., Rampling, R., Kouwenhoven, M. C. M., Kros, J. M., Carpentier, A. F., Clement, P. M., Frenay, M., Campone, M., Baurain, J.-F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5984 · Cited by 575
Wick, W., Puduvalli, V. K., Chamberlain, M. C., van den Bent, M. J., Carpentier, A. F., Cher, L. M., Mason, W., Weller, M., Hong, S., Musib, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2595 · Cited by 525
Reardon, D. A., Fink, K. L., Mikkelsen, T., Cloughesy, T. F., O'Neill, A., Plotkin, S., Glantz, M., Ravin, P., Raizer, J. J., Rich, K. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7510 · Cited by 481
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
Perry, J. R., Bélanger, K., Mason, W. P., Fulton, D., Kavan, P., Easaw, J., Shields, C., Kirby, S., Macdonald, D. R., Eisenstat, D. D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5520 · Cited by 384
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
Park, J. K., Hodges, T., Arko, L., Shen, M., Dello Iacono, D., McNabb, A., Olsen Bailey, N., Kreisl, T. N., Iwamoto, F. M., Sul, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0582 · Cited by 359
Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme
Barker, F. G., Chang, S. M., Gutin, P. H., Malec, M. K., McDermott, M. W., Prados, M. D., & Wilson, C. B. (1998) · Neurosurgery · doi:10.1097/00006123-199804000-00013 · Cited by 330
Combs, S. E., Thilmann, C., Edler, L., Debus, J., & Schulz-Ertner, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4157 · Cited by 325
Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
Brada, M., Stenning, S., Gabe, R., Thompson, L. C., Levy, D., Rampling, R., Erridge, S., Saran, F., Gattamaneni, R., Hopkins, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1932 · Cited by 249
Narayana, A., Kelly, P., Golfinos, J., Parker, E., Johnson, G., Knopp, E., Zagzag, D., Fischer, I., Raza, S., Medabalmi, P., et al. (2009) · Journal of Neurosurgery · doi:10.3171/2008.4.17492 · Cited by 243
de Groot, J. F., Lamborn, K. R., Chang, S. M., Gilbert, M. R., Cloughesy, T. F., Aldape, K., Yao, J., Jackson, E. F., Lieberman, F., Robins, H. I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.1636 · Cited by 228
Helseth, R., Helseth, E., Johannesen, T. B., Langberg, C. W., Lote, K., Rønning, P., Scheie, D., Vik, A., & Meling, T. R. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01350.x · Cited by 215
Multiple resections for patients with glioblastoma: prolonging survival: Clinical article
Chaichana, K. L., Zadnik, P., Weingart, J. D., Olivi, A., Gallia, G. L., Blakeley, J., Lim, M., Brem, H., & Quiñones-Hinojosa, A. (2013) · Journal of Neurosurgery · doi:10.3171/2012.9.jns1277 · Cited by 208
Reardon, D. A., Desjardins, A., Vredenburgh, J. J., Gururangan, S., Sampson, J. H., Sathornsumetee, S., McLendon, R. E., Herndon, J. E., Marcello, J. E., Norfleet, J., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605412 · Cited by 206
Carson, K. A., Grossman, S. A., Fisher, J. D., & Shaw, E. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1661 · Cited by 205
Stummer, W., van den Bent, M. J., & Westphal, M. (2011) · Acta Neurochirurgica · doi:10.1007/s00701-011-1001-x · Cited by 188
Raizer, J. J., Grimm, S., Chamberlain, M. C., Nicholas, M. K., Chandler, J. P., Muro, K., Dubner, S., Rademaker, A. W., Renfrow, J., & Bredel, M. (2010) · Cancer · doi:10.1002/cncr.25462 · Cited by 149
Keles, G. E., Lamborn, K. R., Chang, S. M., Prados, M. D., & Berger, M. S. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.100.1.0041 · Cited by 120
Combs, S. E., Edler, L., Rausch, R., Welzel, T., Wick, W., & Debus, J. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.692882 · Cited by 120
Clarke, J. L., Ennis, M. M., Yung, W. K. A., Chang, S. M., Wen, P. Y., Cloughesy, T. F., DeAngelis, L. M., Robins, H. I., Lieberman, F. S., Fine, H. A., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor110 · Cited by 116
Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy
Mandl, E. S., Dirven, C. M. F., Buis, D. R., Postma, T. J., & Vandertop, W. P. (2008) · Surgical Neurology · doi:10.1016/j.surneu.2007.03.043 · Cited by 111
Kong, D., Lee, J.-I., Kim, J. H., Kim, S. T., Kim, W. S., Suh, Y., Dong, S. M., & Nam, D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop030 · Cited by 100
Brandes, A. A., Tosoni, A., Franceschi, E., Blatt, V., Santoro, A., Faedi, M., Amistà, P., Gardiman, M. P., Labianca, R., Bianchini, C., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0926-8 · Cited by 99
Reardon, D. A., Desjardins, A., Peters, K. B., Vredenburgh, J. J., Gururangan, S., Sampson, J. H., McLendon, R. E., Herndon, J. E., Sykes, A. D., Threatt, S., et al. (2011) · Cancer · doi:10.1002/cncr.26188 · Cited by 88
Benefit of tumor resection for recurrent glioblastoma
Quick, J., Gessler, F. A., Duetzmann, S., Hattingen, E., Harter, P. N., Weise, L. M., Franz, K., Seifert, V., & Senft, C. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1397-2 · Cited by 81
Self-citationScoccianti, S., Detti, B., Sardaro, A., Iannalfi, A., Meattini, I., Leonulli, B. G., Borghesi, S., Martinelli, F., Bordi, L., Ammannati, F., et al. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283005075 · Cited by 66
Balmaceda, C. M., Peereboom, D. M., Pannullo, S. C., Cheung, Y. K., Fisher, P. G., Alavi, J. Β., Sisti, M. B., Chen, J., & Fine, R. L. (2008) · Cancer · doi:10.1002/cncr.23167 · Cited by 61
Fabrini, M. G., Silvano, G., Lolli, I. R., Perrone, F., Marsella, A., Scotti, V., & Cionini, L. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9739-6 · Cited by 61
Surgical outcomes in recurrent glioma: Clinical article
Hoover, J. M., Nwojo, M. E., Puffer, R. C., Mandrekar, J. N., Meyer, F. B., & Parney, I. F. (2013) · Journal of neurosurgery · doi:10.3171/2013.2.jns121731 · Cited by 58
Extended-schedule dose-dense temozolomide in refractory gliomas
GENOM Cooperative Group, Berrocal, A., Segura, P. P., Gil, M., Balañá, C., López, J. G., Yayá, R., Rodríguez, J., Reynés, G., Gallego, O. S., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9980-7 · Cited by 56
Groves, M. D., Puduvalli, V. K., GILBERT, M. R., Levin, V. A., Conrad, C. A., Liu, V., Hunter, K., Meyers, C., Hess, K. R., & Yung, W. K. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605189 · Cited by 50
Reoperation for malignant astrocytoma
Vick, N. A., Ciric, I. S., Eller, T. W., et al. (1989) · Neurology · doi:10.1212/wnl.39.3.430 · Cited by 42
Cited by
Management of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wu, W., Klockow, J. L., Zhang, M., Lafortune, F., Chang, E., Jin, L., Wu, Y., & Daldrup-Link, H. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105780 · Cited by 805
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Suchorska, B., Weller, M., Tabatabai, G., Senft, C., Hau, P., Sabel, M. C., Herrlinger, U., Ketter, R., Schlegel, U., Marosi, C., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov326 · Cited by 254
Self-citation
Metadata
- Authors
- Ringel, F., Pape, H., Sabel, M., Krex, D., Bock, H. C., Misch, M., Weyerbrock, A., Westermaier, T., Senft, C., Schucht, P., Meyer, B., & Simon, M.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-04
- Volume
- 18
- Issue
- 1
- Pages
- 96-104
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W1860764269
- Cited by
- 267
- References
- 42
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.